0001104659-16-121557.txt : 20160517
0001104659-16-121557.hdr.sgml : 20160517
20160517113101
ACCESSION NUMBER: 0001104659-16-121557
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160516
FILED AS OF DATE: 20160517
DATE AS OF CHANGE: 20160517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lynch Shawn
CENTRAL INDEX KEY: 0001674756
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 161656536
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
a4.xml
4
X0306
4
2016-05-16
0
0001492674
T2 Biosystems, Inc.
TTOO
0001674756
Lynch Shawn
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
8.88
2016-05-16
4
A
0
146600
0
A
2026-05-16
Common Stock
146600
146600
D
25% of the total shares vest on 05/16/2017, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 05/16/2020.
/s/ Chris Martin, Attorney-in-fact
2016-05-17